Detalhe da pesquisa
1.
Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study.
Blood
; 141(1): 11-21, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054922
2.
Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study.
Blood
; 141(23): 2867-2877, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36893453
3.
Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry.
Br J Haematol
; 204(4): 1476-1482, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267268
4.
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
Br J Haematol
; 198(3): 535-544, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438802
5.
Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study.
Blood
; 136(26): 3056-3061, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32814348
6.
Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM).
Transfusion
; 62(5): 961-973, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452143
7.
Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment.
Am J Hematol
; 97(1): 10-17, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661954
8.
Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents.
Blood
; 142(12): 1099-1101, 2023 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478400
9.
An updated list of drugs suspected to be associated with immune thrombocytopenia based on the WHO pharmacovigilance database.
Blood
; 140(8): 922-927, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802846
10.
Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes.
Haematologica
; 104(3): 497-504, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30287621
11.
Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.
Am J Hematol
; 94(12): 1314-1324, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31489694
12.
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.
Blood
; 128(12): 1625-30, 2016 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27354722
13.
Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.
Eur J Haematol
; 2018 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29719933
14.
Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia.
Br J Haematol
; 198(3): 595-599, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538740
15.
Blood transfusion in hematologic intensive care unit.
Transfusion
; 57(2): 296-302, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27861958
16.
Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study.
Am J Hematol
; 97(2): E40-E44, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779031
17.
Does eventually NPM1 mutation in blast phase chronic myeloid leukemia (BP-CML) exist? That is the question.
Br J Haematol
; 195(3): 469-471, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34396510
18.
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients.
Blood
; 124(22): 3228-36, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25293768
19.
Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study.
Haematologica
; 101(3): 336-45, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26703963
20.
A randomized phase II trial of azacitidine +/- epoetin-ß in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents.
Haematologica
; 101(8): 918-25, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27229713